​

Funding Round

Series C - Ribon Therapeutics

Series C - Ribon Therapeutics

Investment Firm

Overview

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

Announced Date

Jun 14, 2021

Closed on Date

Jul 14, 2021

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

U.S. Venture Partners

U.S. Venture Partners

U.S. Venture Partners is a early_stage_venture and late_stage_venture and venture firm.

Deerfield

Deerfield

Deerfield is a debt and early_stage_venture firm.

Participant Investors

11

Investor Name
Participant InvestorDeerfield
Participant InvestorThe Column Group
Participant InvestorGoogle Ventures
Participant InvestorOUP (Osage University Partners)
Participant InvestorU.S. Venture Partners

Round Details and Background

Ribon Therapeutics raised $65000000 on 2021-06-14 in Series C

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 22, 2022
Venture Round - Ribon Therapeutics
1-25.0M
Apr 26, 2022
Debt Financing - Ribon Therapeutics
1-50.0M
Oct 10, 2017
Venture Round - Ribon Therapeutics
-20.0M
Dec 16, 2015
Venture Round - Ribon Therapeutics
3-10.0M

Recent Activity

There is no recent news or activity for this profile.